Innovating targeting
Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions
Innovating targeting
Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions
OUR SCIENCES
Learn about our strategy
PIPELINE
Learn more about our pipeline
WORK WITH US
Look at open positions
